The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand
The purpose of this report is to advise the Thai government and Thai society at large about the full range of benefits, costs, and consequences that are likely to result from the decision to expand public provision of antiretroviral therapy (ART) t...
| Main Authors: | , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Publication |
| Language: | English en_US |
| Published: |
Washington, DC: World Bank
2012
|
| Subjects: | |
| Online Access: | http://documents.worldbank.org/curated/en/2006/01/7082805/economics-effective-aids-treatment-evaluating-policy-options-thailand http://hdl.handle.net/10986/7196 |
| id |
okr-10986-7196 |
|---|---|
| recordtype |
oai_dc |
| repository_type |
Digital Repository |
| institution_category |
Foreign Institution |
| institution |
Digital Repositories |
| building |
World Bank Open Knowledge Repository |
| collection |
World Bank |
| language |
English en_US |
| topic |
ACQUIRED IMMUNODEFICIENCY SYNDROME AIDS COMMITTEE AIDS DEATHS AIDS EPIDEMIC AIDS PATIENTS AIDS SPENDING AIDS TREATMENT BEHAVIORAL CHANGE BEHAVIORAL SURVEILLANCE BLOOD DONORS CANCER CASE OF AIDS CELL COUNT CLINICS COMMERCIAL SEX COMMERCIAL SEX WORKERS COMPLICATIONS COMPREHENSIVE CARE CONDOM CONDOM DISTRIBUTION CONDOM USE CONDOMS CONSISTENT USE OF CONDOMS COST EFFECTIVENESS DEVELOPING COUNTRIES DIAGNOSTIC TESTS DISCRIMINATION DISEASE DISEASES DISSEMINATION DISTRICT HOSPITAL DOSE COMBINATION DRUG REGIMENS DRUG USER DRUGS EPIDEMIOLOGY EXTRAMARITAL SEX FEMALE SEX PARTNERS FEMALE SEX WORKERS GLOBAL AIDS PROGRAM GOVERNMENT AGENCIES HEALTH HEALTH CARE HEALTH INSURANCE HEALTH POLICY HEALTH SECTOR HEALTH SYSTEM HEART DISEASE HIGH-RISK HIGH-RISK BEHAVIOR HIGH-RISK GROUPS HIV HIV INFECTED PEOPLE HIV INFECTIONS HIV PREVENTION HIV TESTING HIV TRANSMISSION HIV-POSITIVE PEOPLE HOSPITAL HOSPITALS HOUSEHOLD INCOME HUMAN DEVELOPMENT HUMAN IMMUNODEFICIENCY VIRUS ILLNESS IMMUNE SYSTEMS IMMUNODEFICIENCY IMPACT ON HEALTH INSURANCE SCHEMES INTERVENTION INTRAVENOUS DRUG USERS LAB TESTS LARGE NUMBERS OF PEOPLE LEGAL STATUS LONGEVITY MALARIA MALE SEX MEDICAL CARE MEDICAL SERVICES MENINGITIS MODE OF TRANSMISSION MOTHER MOTHER-TO-CHILD NATIONAL AIDS NATIONAL AIDS PREVENTION NATIONAL RESOURCES NEEDLE SHARING NEW AIDS CASES NEW CASES NEW INFECTIONS NUCLEOSIDE REVERSE NUMBER OF PEOPLE NUTRITION OPPORTUNISTIC ILLNESSES OPPORTUNISTIC INFECTION OPPORTUNISTIC INFECTIONS OUTPATIENT DEPARTMENT PATIENT PATIENT CHOICE PEOPLE LIVING WITH AIDS PNEUMONIA POLICY MAKERS PREGNANT WOMEN PREVALENCE PREVALENCE RATE PREVALENCE RATES PREVENTION ACTIVITIES PREVENTION EFFORTS PREVENTION OF MOTHER PREVENTION OF MOTHER-TO-CHILD TRANSMISSION PROTEASE INHIBITOR PROTEASE INHIBITORS PUBLIC HEALTH PUBLIC HOSPITALS PUBLIC POLICY RESISTANT STRAINS RISK BEHAVIOR RISK BEHAVIORS RISK OF TRANSMISSION RISKY BEHAVIORS SECOND-LINE REGIMENS SERVICE DELIVERY SERVICE PROVIDERS SEX WITH MEN SEX WORKERS SEXUAL CONTACT SEXUAL RELATIONSHIPS SEXUALLY TRANSMITTED INFECTIONS SOCIAL DEVELOPMENT SOCIAL SECURITY SPILLOVER T-CELL THERAPY TRANSMISSION TRIPLE-DRUG COMBINATION TUBERCULOSIS UNAIDS VIRAL LOADS VOLUNTARY COUNSELING WORLD HEALTH ORGANIZATION YOUTH |
| spellingShingle |
ACQUIRED IMMUNODEFICIENCY SYNDROME AIDS COMMITTEE AIDS DEATHS AIDS EPIDEMIC AIDS PATIENTS AIDS SPENDING AIDS TREATMENT BEHAVIORAL CHANGE BEHAVIORAL SURVEILLANCE BLOOD DONORS CANCER CASE OF AIDS CELL COUNT CLINICS COMMERCIAL SEX COMMERCIAL SEX WORKERS COMPLICATIONS COMPREHENSIVE CARE CONDOM CONDOM DISTRIBUTION CONDOM USE CONDOMS CONSISTENT USE OF CONDOMS COST EFFECTIVENESS DEVELOPING COUNTRIES DIAGNOSTIC TESTS DISCRIMINATION DISEASE DISEASES DISSEMINATION DISTRICT HOSPITAL DOSE COMBINATION DRUG REGIMENS DRUG USER DRUGS EPIDEMIOLOGY EXTRAMARITAL SEX FEMALE SEX PARTNERS FEMALE SEX WORKERS GLOBAL AIDS PROGRAM GOVERNMENT AGENCIES HEALTH HEALTH CARE HEALTH INSURANCE HEALTH POLICY HEALTH SECTOR HEALTH SYSTEM HEART DISEASE HIGH-RISK HIGH-RISK BEHAVIOR HIGH-RISK GROUPS HIV HIV INFECTED PEOPLE HIV INFECTIONS HIV PREVENTION HIV TESTING HIV TRANSMISSION HIV-POSITIVE PEOPLE HOSPITAL HOSPITALS HOUSEHOLD INCOME HUMAN DEVELOPMENT HUMAN IMMUNODEFICIENCY VIRUS ILLNESS IMMUNE SYSTEMS IMMUNODEFICIENCY IMPACT ON HEALTH INSURANCE SCHEMES INTERVENTION INTRAVENOUS DRUG USERS LAB TESTS LARGE NUMBERS OF PEOPLE LEGAL STATUS LONGEVITY MALARIA MALE SEX MEDICAL CARE MEDICAL SERVICES MENINGITIS MODE OF TRANSMISSION MOTHER MOTHER-TO-CHILD NATIONAL AIDS NATIONAL AIDS PREVENTION NATIONAL RESOURCES NEEDLE SHARING NEW AIDS CASES NEW CASES NEW INFECTIONS NUCLEOSIDE REVERSE NUMBER OF PEOPLE NUTRITION OPPORTUNISTIC ILLNESSES OPPORTUNISTIC INFECTION OPPORTUNISTIC INFECTIONS OUTPATIENT DEPARTMENT PATIENT PATIENT CHOICE PEOPLE LIVING WITH AIDS PNEUMONIA POLICY MAKERS PREGNANT WOMEN PREVALENCE PREVALENCE RATE PREVALENCE RATES PREVENTION ACTIVITIES PREVENTION EFFORTS PREVENTION OF MOTHER PREVENTION OF MOTHER-TO-CHILD TRANSMISSION PROTEASE INHIBITOR PROTEASE INHIBITORS PUBLIC HEALTH PUBLIC HOSPITALS PUBLIC POLICY RESISTANT STRAINS RISK BEHAVIOR RISK BEHAVIORS RISK OF TRANSMISSION RISKY BEHAVIORS SECOND-LINE REGIMENS SERVICE DELIVERY SERVICE PROVIDERS SEX WITH MEN SEX WORKERS SEXUAL CONTACT SEXUAL RELATIONSHIPS SEXUALLY TRANSMITTED INFECTIONS SOCIAL DEVELOPMENT SOCIAL SECURITY SPILLOVER T-CELL THERAPY TRANSMISSION TRIPLE-DRUG COMBINATION TUBERCULOSIS UNAIDS VIRAL LOADS VOLUNTARY COUNSELING WORLD HEALTH ORGANIZATION YOUTH Revenga, Ana Over, Mead Masaki, Emiko Peerapatanapokin, Wiwat Gold, Julian Tangcharoensathien, Viroj Thanprasertsuk, Sombat The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand |
| geographic_facet |
East Asia and Pacific Asia Southeast Asia Thailand |
| relation |
Health, Nutrition, and Population |
| description |
The purpose of this report is to advise
the Thai government and Thai society at large about the full
range of benefits, costs, and consequences that are likely
to result from the decision to expand public provision of
antiretroviral therapy (ART) through National Access to
Antiretroviral Program for People Living with HIV/AIDS
(NAPHA) and to assist with the design of implementation
policies that will achieve maximum treatment benefits, while
promoting prevention of HIV/AIDS and maintaining financial
sustainability within Thailand. The study has several
significant findings: NAPHA with first-line regimen only is
the most cost-effective policy option of those studied;
NAPHA with second-line therapy is still affordable and
yields large benefits in terms of life-years saved; policy
options to enhance adherence and to recruit patients earlier
are a good public investment; public financing will help
ensure equitable access; public financing can strengthen
positive spillovers and can limit negative spillovers of
ART; if the success of ART rollout makes people or the
government complacent about prevention, future costs could
rise substantially; and future government expenditures on
ART, and the lives it will save are highly sensitive to
negotiated agreements on the intellectual property rights
for pharmaceuticals. In its current form, Thailand's
NAPHA program is affordable. Under the model's
assumptions, it is also cost-effective relative to the
baseline scenario. Furthermore, although the two enhanced
policies we suggest early recruitment through expanded
voluntary counseling and testing (VCT) and improved
adherence through Person living with HIV/AIDS (PHA) groups
are less cost-effective, they are still a good bargain,
particularly if both are enacted. |
| author2 |
Brown, Tim |
| author_facet |
Brown, Tim Revenga, Ana Over, Mead Masaki, Emiko Peerapatanapokin, Wiwat Gold, Julian Tangcharoensathien, Viroj Thanprasertsuk, Sombat |
| format |
Publications & Research :: Publication |
| author |
Revenga, Ana Over, Mead Masaki, Emiko Peerapatanapokin, Wiwat Gold, Julian Tangcharoensathien, Viroj Thanprasertsuk, Sombat |
| author_sort |
Revenga, Ana |
| title |
The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand |
| title_short |
The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand |
| title_full |
The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand |
| title_fullStr |
The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand |
| title_full_unstemmed |
The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand |
| title_sort |
economics of effective aids treatment : evaluating policy options for thailand |
| publisher |
Washington, DC: World Bank |
| publishDate |
2012 |
| url |
http://documents.worldbank.org/curated/en/2006/01/7082805/economics-effective-aids-treatment-evaluating-policy-options-thailand http://hdl.handle.net/10986/7196 |
| _version_ |
1764399301027430400 |
| spelling |
okr-10986-71962021-04-23T14:02:27Z The Economics of Effective AIDS Treatment : Evaluating Policy Options for Thailand Revenga, Ana Over, Mead Masaki, Emiko Peerapatanapokin, Wiwat Gold, Julian Tangcharoensathien, Viroj Thanprasertsuk, Sombat Brown, Tim Duncombe, Chris Lertiendumrong, Jongkol Phongphit, Seri Tantisak, Bussaba Wilson, David ACQUIRED IMMUNODEFICIENCY SYNDROME AIDS COMMITTEE AIDS DEATHS AIDS EPIDEMIC AIDS PATIENTS AIDS SPENDING AIDS TREATMENT BEHAVIORAL CHANGE BEHAVIORAL SURVEILLANCE BLOOD DONORS CANCER CASE OF AIDS CELL COUNT CLINICS COMMERCIAL SEX COMMERCIAL SEX WORKERS COMPLICATIONS COMPREHENSIVE CARE CONDOM CONDOM DISTRIBUTION CONDOM USE CONDOMS CONSISTENT USE OF CONDOMS COST EFFECTIVENESS DEVELOPING COUNTRIES DIAGNOSTIC TESTS DISCRIMINATION DISEASE DISEASES DISSEMINATION DISTRICT HOSPITAL DOSE COMBINATION DRUG REGIMENS DRUG USER DRUGS EPIDEMIOLOGY EXTRAMARITAL SEX FEMALE SEX PARTNERS FEMALE SEX WORKERS GLOBAL AIDS PROGRAM GOVERNMENT AGENCIES HEALTH HEALTH CARE HEALTH INSURANCE HEALTH POLICY HEALTH SECTOR HEALTH SYSTEM HEART DISEASE HIGH-RISK HIGH-RISK BEHAVIOR HIGH-RISK GROUPS HIV HIV INFECTED PEOPLE HIV INFECTIONS HIV PREVENTION HIV TESTING HIV TRANSMISSION HIV-POSITIVE PEOPLE HOSPITAL HOSPITALS HOUSEHOLD INCOME HUMAN DEVELOPMENT HUMAN IMMUNODEFICIENCY VIRUS ILLNESS IMMUNE SYSTEMS IMMUNODEFICIENCY IMPACT ON HEALTH INSURANCE SCHEMES INTERVENTION INTRAVENOUS DRUG USERS LAB TESTS LARGE NUMBERS OF PEOPLE LEGAL STATUS LONGEVITY MALARIA MALE SEX MEDICAL CARE MEDICAL SERVICES MENINGITIS MODE OF TRANSMISSION MOTHER MOTHER-TO-CHILD NATIONAL AIDS NATIONAL AIDS PREVENTION NATIONAL RESOURCES NEEDLE SHARING NEW AIDS CASES NEW CASES NEW INFECTIONS NUCLEOSIDE REVERSE NUMBER OF PEOPLE NUTRITION OPPORTUNISTIC ILLNESSES OPPORTUNISTIC INFECTION OPPORTUNISTIC INFECTIONS OUTPATIENT DEPARTMENT PATIENT PATIENT CHOICE PEOPLE LIVING WITH AIDS PNEUMONIA POLICY MAKERS PREGNANT WOMEN PREVALENCE PREVALENCE RATE PREVALENCE RATES PREVENTION ACTIVITIES PREVENTION EFFORTS PREVENTION OF MOTHER PREVENTION OF MOTHER-TO-CHILD TRANSMISSION PROTEASE INHIBITOR PROTEASE INHIBITORS PUBLIC HEALTH PUBLIC HOSPITALS PUBLIC POLICY RESISTANT STRAINS RISK BEHAVIOR RISK BEHAVIORS RISK OF TRANSMISSION RISKY BEHAVIORS SECOND-LINE REGIMENS SERVICE DELIVERY SERVICE PROVIDERS SEX WITH MEN SEX WORKERS SEXUAL CONTACT SEXUAL RELATIONSHIPS SEXUALLY TRANSMITTED INFECTIONS SOCIAL DEVELOPMENT SOCIAL SECURITY SPILLOVER T-CELL THERAPY TRANSMISSION TRIPLE-DRUG COMBINATION TUBERCULOSIS UNAIDS VIRAL LOADS VOLUNTARY COUNSELING WORLD HEALTH ORGANIZATION YOUTH The purpose of this report is to advise the Thai government and Thai society at large about the full range of benefits, costs, and consequences that are likely to result from the decision to expand public provision of antiretroviral therapy (ART) through National Access to Antiretroviral Program for People Living with HIV/AIDS (NAPHA) and to assist with the design of implementation policies that will achieve maximum treatment benefits, while promoting prevention of HIV/AIDS and maintaining financial sustainability within Thailand. The study has several significant findings: NAPHA with first-line regimen only is the most cost-effective policy option of those studied; NAPHA with second-line therapy is still affordable and yields large benefits in terms of life-years saved; policy options to enhance adherence and to recruit patients earlier are a good public investment; public financing will help ensure equitable access; public financing can strengthen positive spillovers and can limit negative spillovers of ART; if the success of ART rollout makes people or the government complacent about prevention, future costs could rise substantially; and future government expenditures on ART, and the lives it will save are highly sensitive to negotiated agreements on the intellectual property rights for pharmaceuticals. In its current form, Thailand's NAPHA program is affordable. Under the model's assumptions, it is also cost-effective relative to the baseline scenario. Furthermore, although the two enhanced policies we suggest early recruitment through expanded voluntary counseling and testing (VCT) and improved adherence through Person living with HIV/AIDS (PHA) groups are less cost-effective, they are still a good bargain, particularly if both are enacted. 2012-06-05T20:59:23Z 2012-06-05T20:59:23Z 2006 http://documents.worldbank.org/curated/en/2006/01/7082805/economics-effective-aids-treatment-evaluating-policy-options-thailand 978-0-8213-6755-1 http://hdl.handle.net/10986/7196 English en_US Health, Nutrition, and Population CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo World Bank Washington, DC: World Bank Publications & Research :: Publication Publications & Research :: Publication East Asia and Pacific Asia Southeast Asia Thailand |